Speaker illustration

Doctor Benjamin Munoz Calvo

Hospital Universitario Príncipe de Asturias , Alcala de Henares (Spain)

Sacubitril-valsartan treatment furtherly improves response to intermittent parenteral levosimendan in ambulatory patients with advanced heart failure with reduced ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Evidence of pericardial abnormalities with potential haemodynamic significance is frequent in HFpEF patients: causalty or causality?

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Thumbnail

This platform is supported by

logo Novo Nordisk